Prevention of hepatocellular carcinoma and monitoring of high-risk patients.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 33, doi. 10.14744/hf.2021.2021.0033
- By:
- Publication type:
- Article
Works matching IS 13075888 AND DT 2022 AND VI 3 AND IP 1
Results: 8
1
2
Graft versus host disease after liver transplantation: A case report.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 30, doi. 10.14744/hf.2021.2021.0006
- By:
- Publication type:
- Article
3
Liver biochemical flare with immune checkpoint therapy in metastatic Merkel cell carcinoma: A liver biopsy is always necessary.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 27, doi. 10.14744/hf.2021.2021.0036
- By:
- Publication type:
- Article
4
Effects of black cumin seed oil on oxidative stress and expression of membrane-cytoskeleton linker proteins, radixin, and moesin in streptozotocin-induced diabetic rat liver.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 21, doi. 10.14744/hf.2021.2021.0035
- By:
- Publication type:
- Article
5
Histopathological effects of Algan hemostatic agent (AHA) in liver injury model in rats.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 16, doi. 10.14744/hf.2021.2021.0040
- By:
- Publication type:
- Article
6
Changes in the clinical characteristics of chronic hepatitis B patients at the initiation of treatment over a 15-year period.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 11, doi. 10.14744/hf.2021.2021.0030
- By:
- Publication type:
- Article
7
Baseline characteristics associated with survival in patients with hepatocellular carcinoma.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 3, doi. 10.14744/hf.2021.2021.0031
- By:
- Publication type:
- Article
8
The use of HCV positive donors among non-HCV infected liver transplant recipients.
- Published in:
- Hepatology Forum, 2022, v. 3, n. 1, p. 1, doi. 10.14744/hf.2021.2021.0048
- By:
- Publication type:
- Article